lithium has been researched along with buspirone in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (65.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schneider, LS; Sobin, PB | 1 |
| Coplan, JD; Gorman, JM | 1 |
| Aronson, SC; Barr, LC; Goodman, WK; McDougle, CJ; Price, LH | 1 |
| Joffe, RT; Levitt, AJ; Sokolov, ST | 1 |
| Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH | 1 |
| Duman, RS; Heninger, GR; Malison, RT; Nestler, EJ; Price, LH | 1 |
| Joffe, RT; Sussman, N | 2 |
| Friedman, ES; Howland, RH; Thase, ME | 1 |
| Nelson, JC | 2 |
| Cadieux, RJ | 1 |
| Fawcett, J; Kravitz, GS; Kravitz, HM; McGuire, M; Whitney, M | 1 |
| Fava, M | 1 |
| Megna, J; O'dell, M | 1 |
| Albertini, RS; Khan, A; Phillips, KA; Robinson, M; Siniscalchi, JM | 1 |
| Agüera, L; de la Gándara, J; de Pedro, JM; Rojo, JE; Ros, S | 1 |
| Fragala, MR; Holmes, TF; Sabaawi, M | 1 |
| Berrocoso, E; González-Saiz, F; Mico, JA; Perez-Caballero, L; Romero-López-Alberca, C; Torres-Sanchez, S | 1 |
| Buoli, M; Caldiroli, A; Capellazzi, M; Capuzzi, E; Clerici, M; Colmegna, F; Dakanalis, A; Marcatili, M; Mucci, F; Tagliabue, I | 1 |
14 review(s) available for lithium and buspirone
| Article | Year |
|---|---|
Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementia.
Topics: Adrenergic beta-Antagonists; Alzheimer Disease; Buspirone; Carbamazepine; Dementia; Humans; Lithium; Neurotransmitter Uptake Inhibitors; Selegiline; Serotonin; Trazodone | 1992 |
Treatment of anxiety disorder in patients with mood disorders.
Topics: Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Depressive Disorder; Humans; Lithium; Psychotherapy; Valproic Acid | 1990 |
Biological approaches to treatment-resistant obsessive compulsive disorder.
Topics: Behavior Therapy; Buspirone; Clonazepam; Combined Modality Therapy; Decision Trees; Drug Therapy, Combination; Electroconvulsive Therapy; Fenfluramine; Humans; Lithium; Obsessive-Compulsive Disorder; Phototherapy; Selective Serotonin Reuptake Inhibitors; Sleep Deprivation; Trazodone; Tryptophan | 1993 |
Augmentation strategies: focus on anxiolytics.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Buspirone; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lithium; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triiodothyronine | 1996 |
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
Treating antidepressant nonresponders with augmentation strategies: an overview.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Lithium; Pindolol; Severity of Illness Index; Thyroid Hormones; Treatment Outcome | 1998 |
Overcoming treatment resistance in depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Lithium; Pindolol; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triiodothyronine | 1998 |
Practical management of treatment-resistant depression.
Topics: Antidepressive Agents; Buspirone; Depression; Drug Resistance; Drug Therapy, Combination; Humans; Lithium; Pindolol; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Triiodothyronine | 1998 |
New approaches to the treatment of refractory depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Pindolol; Piperazines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thyroxine; Triazoles; Triiodothyronine | 2000 |
Augmentation strategies in depression 2000.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Buspirone; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Monoamine Oxidase Inhibitors; Pindolol; Selective Serotonin Reuptake Inhibitors; Triiodothyronine; Tryptophan | 2000 |
Potentiation strategies for treatment-resistant depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Lithium; Treatment Outcome; Triiodothyronine | 2005 |
Drug-induced akathisia: subjective experience and objective findings.
Topics: Akathisia, Drug-Induced; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Buspirone; Fluoxetine; Humans; Lithium; Risk Factors | 1994 |
Monoaminergic system and depression.
Topics: Antidepressive Agents; Antipsychotic Agents; Biogenic Monoamines; Buspirone; Depressive Disorder, Major; Drug Synergism; Excitatory Amino Acid Agents; Humans; Lithium; Pindolol; Triiodothyronine | 2019 |
Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review.
Topics: Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Second-Generation; Buspirone; Central Nervous System Stimulants; Depressive Disorder, Treatment-Resistant; Humans; Ketamine; Lithium | 2021 |
1 trial(s) available for lithium and buspirone
| Article | Year |
|---|---|
Treatment attrition among alcohol-dependent men: is it related to novelty seeking personality traits?
Topics: Adult; Alcoholism; Buspirone; Double-Blind Method; Humans; Lithium; Male; Multivariate Analysis; Patient Compliance; Personality; Personality Tests; Treatment Outcome | 1999 |
5 other study(ies) available for lithium and buspirone
| Article | Year |
|---|---|
Efficacy of papaverine addition for treatment-refractory major depression.
Topics: Buspirone; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lithium; Middle Aged; Papaverine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Introduction: augmentation of antidepressant medication.
Topics: Anticonvulsants; Antidepressive Agents; Buspirone; Calcium Channel Blockers; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Humans; Lithium; Pindolol; Thyroid Hormones; Treatment Outcome | 1998 |
Antidepressant augmentation: conclusions and recommendations.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Buspirone; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Humans; Lithium; Pindolol; Triiodothyronine | 1998 |
Ataxia from lithium toxicity successfully treated with high-dose buspirone: a single-case experimental design.
Topics: Activities of Daily Living; Ataxia; Bipolar Disorder; Buspirone; Drug Overdose; Female; Humans; Lithium; Middle Aged; Serotonin Receptor Agonists; Suicide, Attempted | 2001 |
Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Buspirone; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Medical Records; Methylphenidate; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Somatoform Disorders; Substance Withdrawal Syndrome; Treatment Outcome | 2001 |